as well as lower-throughput instruments such as the recently announced MiSeq i100 series. These platforms, along with associated consumables and services, form the backbone of Illumina’s revenue ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
The Illumina MiSeq i100 Series, announced last fall ... what they call the "prototype one," or P1, instruments and consumables. Natarajan's initial goal was to construct the bare-bones software ...
The company reported solid growth in sequencing consumables ... recently announced the MiSeq i100 series, which analysts believe could significantly expand Illumina's Total (EPA:TTEF) Addressable ...
The MiSeq desktop sequencer allows access tomore focused applications such as targeted gene sequencing, metagenomics, small genome sequencing, targeted gene expression, amplicon sequencing, and HLA ...
MiSeq reagents enable up to 15 Gb of output with 25 million sequencing reads and 2 × 300 bp read lengths. The MiSeq System can go from DNA to data in just over 8 hours. A compact, all-in-one ...
potentially leading to increased instrument sales and higher consumables pull-through. Illumina’s introduction of the MiSeq i100 series demonstrates the company’s commitment to expanding its product ...
The Illumina MiSeq i100 Series, announced last fall ... a hardware team begins building what they call the "prototype one," or P1, instruments and consumables. Natarajan's initial goal was to ...
SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina ... The XLEAP-SBS chemistry on the MiSeq i100 Series also enables room-temperature ship-and-store consumables, empowering customers to sequence ...